Dsm N.v.

DSM N.V. (RDSMY) Royal DSM N.V. has repurchased 896,247 of its own shares in the period from 12 June 2008 up to and including 18 June 2008 at an average price of EUR 39.91. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 35.8 million.

DSM N.V. (RDSMY) German researcher Andreas Walther has won the first prize in the DSM Science & Technology Awards (South) 2008. An international judging committee, chaired by Dr Manfred Eggersdorfer, R&D Director at DSM Nutritional Products, selected Andreas Walther, who will obtain his doctorate from the University of Bayreuth (Germany), for his PhD research in the field of polymeric materials.

DSM N.V. (RDSMY) DSM Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announce another breakthrough in the production of IgG antibodies using PER.C6® technology. By employing the PER.C6® human cell line and proprietary XD(TM) technology, a record yield of over 27 grams per liter has been achieved. In March 2008 a yield of 15 grams per liter was reported.

DSM N.V. (RDSMY) Royal DSM N.V. has repurchased 783,673 of its own shares in the period from 5 June 2008 up to and including 11 June 2008 at an average price of EUR 38.96. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 30.5 million.

DSM N.V. (RDSMY) Royal DSM N.V. has repurchased 769,914 of its own shares in the period from 29 May 2008 up to and including 4 June 2008 at an average price of EUR 39.17. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 30.2 million.

DSM N.V. (RDSMY) Belgian researcher Maarten Roeffaers of the Catholic University of Leuven has won the first prize in the DSM Science & Technology Awards (North) 2008. An international judging committee, chaired by DSM Chief Technology Officer Dr Jos Put, selected Dr Maarten Roeffaers, who received his doctorate from the Catholic University of Leuven (Belgium), for his PhD thesis entitled 'Heterogeneous Catalysis: a fluorescence microscopic study'. Maarten Roeffaers has pioneered the use of fluorescence microscopy in catalysis research. With his innovative approach he could unravel various steps of the complex catalytic cycle that were previously hidden for other techniques, thus enabling more efficient and 'green' catalyst systems. His work will contribute to the development of efficient chemical processes and thus to a more sustainable economy. Maarten Roeffaers was presented with the award by Mr Jan Zuidam, deputy chairman of DSM's Managing Board. As the winner of the first prize he ...

DSM N.V. (RDSMY) Royal DSM N.V. has repurchased 560,166 of its own shares in the period from 22 May 2008 up to and including 28 May 2008 at an average price of EUR 37.40. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 20.9 million.

DSM N.V. (RDSMY) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has closed the acquisition of The Polymer Technology Group, Inc. (PTG) of Berkeley (California, United States), a market leader in the field of biomedical polymers.